Company intelligence / Profile preview

BioDerm

Largo, Florida, United States

Ownership: Private
Employees: ~128
Development stage: Other

Overview

BioDerm is a commercial-stage medical device company specializing in proprietary hydrocolloid-based products for urinary management, catheter securement, infection control, and skin protection. Their flagship products, such as Men’s Liberty™ for male urinary incontinence, are widely used in both home and acute care settings, with Medicare reimbursement and significant market penetration. The company has a strong focus on improving patient quality of life by reducing complications and infection rates associated with chronic catheter use.

Therapeutic areas: NephrologyInfectious DiseasesDermatology
Modalities: DeviceHydrocolloid dressing
Industry: Therapeutic Medical Devices

Partnerships

MedlineTillaCare, Ltd.Premier Healthcare Alliance

Beyond the preview

Go deeper on BioDerm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioDerm.

Explore the full profile